Polymorphisms are a key consideration in drug development and clinical trials. By understanding genetic variations, pharmaceutical companies can design drugs that are more effective and safer for specific genetic profiles. This approach is part of the broader field of personalized medicine, which aims to tailor medical treatment to the individual characteristics of each patient.
